Mechanism of Modified Erxian Decoction Regulating Perimenopausal Syndrome via SIRT1/Kisspeptin/GnRH Signaling Pathway
|更新时间:2025-10-16
|
Mechanism of Modified Erxian Decoction Regulating Perimenopausal Syndrome via SIRT1/Kisspeptin/GnRH Signaling Pathway
增强出版
“The latest research has found that Jiawei Erxian Tang can multi-target regulate the HPG axis function in perimenopausal syndrome rats, upregulate SIRT1 expression, inhibit excessive activation of the Kisspeptin/GnRH signaling pathway, restore the balance of gonadotropin secretion, and increase estrogen levels.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 22, Pages: 51-62(2025)
HUANG Ruiyu,LEI Fang,LIU Wuchaonan,et al.Mechanism of Modified Erxian Decoction Regulating Perimenopausal Syndrome via SIRT1/Kisspeptin/GnRH Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(22):51-62.
HUANG Ruiyu,LEI Fang,LIU Wuchaonan,et al.Mechanism of Modified Erxian Decoction Regulating Perimenopausal Syndrome via SIRT1/Kisspeptin/GnRH Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(22):51-62. DOI: 10.13422/j.cnki.syfjx.20251101.
Mechanism of Modified Erxian Decoction Regulating Perimenopausal Syndrome via SIRT1/Kisspeptin/GnRH Signaling Pathway增强出版